Physician profile
Jose M David
NPI 1831181981
$102,828.16
in general payments reported to CMS, 2019-2025
75 companies · $16K in 2025
The $16K reported for 2025 was more than what 99% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,355 · 2020: $7,738 · 2021: $14K · 2022: $14K · 2023: $28K · 2024: $22K · 2025: $16K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $43K · Food and Beverage: $16K · Travel and Lodging: $4,222 · Consulting Fee: $2,065 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $42,575.00 |
| Food and Beverage | $16,243.78 |
| Travel and Lodging | $4,222.36 |
| Consulting Fee | $2,065.00 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $29,732.48 | 2021-2025 | Qulipta, Ubrelvy, Linzess |
| Janssen Pharmaceuticals, INC | $28,798.54 | 2019-2025 | Spravato, Invega Sustenna |
| Idorsia Pharmaceuticals US INC | $11,112.37 | 2022-2024 | Quviviq |
| Allergan, INC. | $6,809.23 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $2,708.94 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Sanofi-Aventis U.S. LLC | $2,353.26 | 2019-2025 | |
| Novo Nordisk INC | $1,710.45 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $1,308.43 | 2019-2025 | Zepbound, Mounjaro, Kisunla |
| Gilead Sciences, INC. | $1,051.37 | 2020-2025 | Descovy, Epclusa |
| Amgen INC. | $924.54 | 2019-2024 | Repatha, Evenity, Prolia |
| Astellas Pharma US INC | $896.91 | 2019-2024 | Veozah, Myrbetriq |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $831.48 | 2019-2025 | Xifaxan |
| Pfizer INC. | $783.58 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $778.48 | 2021-2025 | |
| Glaxosmithkline, LLC. | $745.24 | 2019-2025 | Arexvy, Trelegy Ellipta, Shingrix |
Show all 75 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axsome Therapeutics, INC. | $707.45 | 2022-2025 | Auvelity |
| Esperion Therapeutics, INC. | $663.19 | 2020-2025 | Nexletol, Nexlizet |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $649.32 | 2021-2025 | Caplyta |
| Neurocrine Biosciences, INC. | $644.82 | 2022-2025 | Ingrezza |
| Braeburn INC. | $559.25 | 2023-2025 | Brixadi |
| Abbott Laboratories | $500.63 | 2021-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Vanda Pharmaceuticals INC. | $485.69 | 2024-2025 | Fanapt |
| Alnylam Pharmaceuticals INC. | $480.66 | 2022-2025 | Givlaari |
| Indivior INC. | $473.94 | 2019-2025 | Sublocade |
| Teva Pharmaceuticals USA, INC. | $445.77 | 2019-2025 | Austedo, Austedo Xr, Austedo Xr |
| Otsuka America Pharmaceutical, INC. | $419.61 | 2021-2025 | Rexulti, Nuedexta |
| Orexo US, INC. | $409.06 | 2019-2025 | Zubsolv |
| Merck Sharp & Dohme LLC | $382.13 | 2019-2025 | Verquvo, Belsomra, Steglatro |
| Alkermes, INC. | $366.43 | 2021-2025 | Lybalvi, Aristada, Vivitrol |
| Renalytix Ai, INC. | $357.14 | 2022-2025 | Kidneyintelx Blood Collection Convenience Kit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $309.95 | 2019-2025 | Jardiance |
| Lundbeck LLC | $273.54 | 2023-2025 | Rexulti |
| Novartis Pharmaceuticals Corporation | $263.67 | 2019-2024 | |
| Kowa Pharmaceuticals America, INC. | $262.08 | 2020-2023 | Seglentis, Livalo |
| Galderma Laboratories, L.P. | $243.13 | 2022 | |
| Eisai INC. | $206.85 | 2020-2024 | |
| Avanir Pharmaceuticals, INC. | $204.91 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $186.30 | 2019-2024 | Trintellix |
| Biohaven Pharmaceuticals, INC. | $182.31 | 2021 | |
| Ibsa Pharma INC. | $170.86 | 2019-2025 | Tirosint, Flector, Licart |
| Daiichi Sankyo INC. | $168.10 | 2020-2021 | |
| Exact Sciences Corporation | $146.34 | 2023-2024 | Cologuard Collection Kit |
| Biohaven Pharmaceutical Holding Company LTD. | $136.53 | 2022 | |
| Dexcom, INC. | $134.19 | 2021-2025 | Dexcom G6 Transmitter |
| Paratek Pharmaceuticals, INC. | $132.60 | 2023-2025 | Nuzyra |
| Phathom Pharmaceuticals, INC. | $131.12 | 2025 | Voquezna |
| Nestle Healthcare Nutrition INC. | $115.92 | 2020-2021 | |
| Urovant Sciences INC | $102.08 | 2022 | |
| Endo Pharmaceuticals INC. | $96.14 | 2020-2021 | |
| Sumitomo Pharma America, INC. | $93.10 | 2023 | Gemtesa |
| Arbor Pharmaceuticals, INC. | $86.64 | 2019-2020 | |
| Bausch Health US, LLC | $83.87 | 2022-2023 | Wellbutrin, Aplenzin |
| Biogen, INC. | $83.11 | 2020-2021 | |
| Sunovion Pharmaceuticals INC. | $81.06 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $75.93 | 2022-2024 | Eliquis, Camzyos |
| Ironwood Pharmaceuticals, INC | $61.88 | 2020-2021 | |
| Ucb, INC. | $60.73 | 2023-2024 | Nayzilam |
| Verona Pharma, INC. | $53.64 | 2025 | Ohtuvayre |
| Seqirus USA INC | $53.45 | 2019-2021 | |
| Collegium Pharmaceutical, INC. | $52.21 | 2023-2024 | Belbuca, Xtampza |
| Scilex Pharmaceuticals INC. | $45.41 | 2019-2022 | |
| Nabriva Therapeutics, Plc | $44.55 | 2020 | |
| Redhill Biopharma INC. | $44.24 | 2020 | |
| Jazz Pharmaceuticals INC. | $40.83 | 2021-2022 | |
| Regeneron Healthcare Solutions, INC. | $39.95 | 2021-2022 | |
| Shield Therapeutics INC | $39.12 | 2023-2024 | Accrufer |
| Vertex Pharmaceuticals Incorporated | $38.45 | 2025 | |
| Amarin Pharma, INC. | $38.01 | 2020-2021 | |
| Optinose US, INC. | $34.38 | 2024-2025 | |
| Medtronic, INC. | $34.35 | 2023 | Inpen Smart Insulin Delivery System |
| Sanofi Pasteur INC. | $19.37 | 2025 | |
| Corcept Therapeutics | $18.95 | 2023 | Korlym |
| Tolmar, INC. | $17.90 | 2025 | Jatenzo |
| Almatica Pharma LLC | $16.63 | 2021 | |
| Acorda Therapeutics, INC | $13.39 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jose David listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.